GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Apontis Pharma AG (XTER:APPH) » Definitions » Interest Expense

Apontis Pharma AG (XTER:APPH) Interest Expense : €-0.16 Mil (TTM As of Jun. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Apontis Pharma AG Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Apontis Pharma AG's interest expense for the six months ended in Jun. 2024 was € -0.14 Mil. Its interest expense for the trailing twelve months (TTM) ended in Jun. 2024 was €-0.16 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Apontis Pharma AG's Operating Income for the six months ended in Jun. 2024 was € 1.00 Mil. Apontis Pharma AG's Interest Expense for the six months ended in Jun. 2024 was € -0.14 Mil. Apontis Pharma AG's Interest Coverage for the quarter that ended in Jun. 2024 was 7.38. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Apontis Pharma AG Interest Expense Historical Data

The historical data trend for Apontis Pharma AG's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Apontis Pharma AG Interest Expense Chart

Apontis Pharma AG Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Interest Expense
Get a 7-Day Free Trial -0.83 -0.87 -0.41 -0.05 -0.07

Apontis Pharma AG Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.03 -0.02 -0.05 -0.02 -0.14

Apontis Pharma AG Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-0.16 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Apontis Pharma AG  (XTER:APPH) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Apontis Pharma AG's Interest Expense for the six months ended in Jun. 2024 was €-0.14 Mil. Its Operating Income for the six months ended in Jun. 2024 was €1.00 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Jun. 2024 was €0.00 Mil.

Apontis Pharma AG's Interest Coverage for the quarter that ended in Jun. 2024 is calculated as

Interest Coverage=-1* Operating Income (Q: Jun. 2024 )/Interest Expense (Q: Jun. 2024 )
=-1*0.996/-0.135
=7.38

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Apontis Pharma AG Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Apontis Pharma AG (XTER:APPH) » Definitions » Interest Expense
Comparable Companies
XTER:B8FK ZTS XTER:MRK NSE:SUNPHARMA LSE:HLN TSE:4502 XSWX:GALD XTAE:TEVA NSE:DIVISLAB XSWX:SDZ VTRS SZSE:000538 NBIX BOM:543904 BOM:500124 NSE:TORNTPHARM HKSE:03692 TSE:4507 BOM:500257 CTLT
Traded in Other Exchanges
APPH:Germany
Address
Alfred-Nobel-Strabe 10, Monheim, BY, DEU, 40789
Website
https://www.apontis-pharma.de
Apontis Pharma AG is a pharmaceutical company specializing in single pills in Germany. single pills combine two to three generic active ingredients in a single dosage form. The company develops, promotes, and sells a broad portfolio of single pills and other pharmaceutical products, with a special focus on cardiovascular diseases. The company markets drugs in the disease areas of respiratory diseases and diabetes as part of co-marketing/co-promotion.
Executives
Thomas Milz Board of Directors
Bruno Wohlschlegel Board of Directors
Thomas Zimmermann Chief Financial Officer
Karlheinz Gast Board of Directors

Apontis Pharma AG Headlines

No Headlines